182 related articles for article (PubMed ID: 37881057)
21. Overexpression of heat shock protein 90 through the downregulation of miR-9-5p in extramammary Paget's disease.
Ohnuma T; Mijiddorj MT; Kajihara I; Sawamura S; Sakamoto R; Maeda-Otsuka S; Yamada-Kanazawa S; Makino K; Aoi J; Masuguchi S; Fukushima S
J Dermatol; 2023 Sep; 50(9):1216-1221. PubMed ID: 37208828
[TBL] [Abstract][Full Text] [Related]
22. KS-EMPD-1: a novel cell line of primary extramammary Paget's disease.
Ito T; Tanaka Y; Ichiki T; Kaku-Ito Y; Nakahara T
Hum Cell; 2023 Sep; 36(5):1813-1829. PubMed ID: 37432591
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical and clinicopathological study regarding nardilysin on extramammary Paget's disease.
Yamaguchi A; Takahashi T; Kato T; Tanaka T; Nishi E; Fujimoto N
Arch Dermatol Res; 2023 Sep; 315(7):1979-1987. PubMed ID: 36867223
[TBL] [Abstract][Full Text] [Related]
24. PIG7/LITAF gene mutation and overexpression of its gene product in extramammary Paget's disease.
Matsumura Y; Matsumura Y; Nishigori C; Horio T; Miyachi Y
Int J Cancer; 2004 Aug; 111(2):218-23. PubMed ID: 15197774
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
[TBL] [Abstract][Full Text] [Related]
26. Frequent
Takeichi T; Okuno Y; Matsumoto T; Tsunoda N; Suzuki K; Tanahashi K; Kono M; Kikumori T; Muro Y; Akiyama M
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32235312
[TBL] [Abstract][Full Text] [Related]
27. MiR-155, a potential serum marker of extramammary Paget's disease.
Guo H; Qi RQ; Sheng J; Liu C; Ma H; Wang HX; Li JH; Gao XH; Wan YS; Chen HD
BMC Cancer; 2018 Nov; 18(1):1078. PubMed ID: 30458743
[TBL] [Abstract][Full Text] [Related]
28. Extramammary Paget's disease: evaluation of the histopathological patterns of Paget cell proliferation in the epidermis.
Shiomi T; Yoshida Y; Shomori K; Yamamoto O; Ito H
J Dermatol; 2011 Nov; 38(11):1054-1057. PubMed ID: 21950591
[TBL] [Abstract][Full Text] [Related]
29. Cyclin-dependent kinase 4/6 inhibitors suppress tumor growth in extramammary Paget's disease.
Kitamura S; Yanagi T; Maeda T; Ujiie H
Cancer Sci; 2022 Feb; 113(2):802-807. PubMed ID: 34866279
[TBL] [Abstract][Full Text] [Related]
30. Extramammary Paget's disease: a report of three cases and review of the literature.
Png JC; Tung KH; Wong YE; Mokal N; Rajagopalan R; Chong PY
Ann Acad Med Singap; 1995 Jul; 24(4):636-9. PubMed ID: 8849202
[TBL] [Abstract][Full Text] [Related]
31. Extramammary Paget's disease patient-derived xenografts harboring ERBB2 S310F mutation show sensitivity to HER2-targeted therapies.
Maeda T; Kitamura S; Nishihara H; Yanagi T
Oncogene; 2020 Sep; 39(36):5867-5875. PubMed ID: 32724160
[TBL] [Abstract][Full Text] [Related]
32. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target.
Nakamura Y; Mizukami H; Tanese K; Fusumae T; Hirai I; Amagai M; Takamatsu R; Nakamura K; Nishihara H; Takimoto T; Ueno M; Saya H; Funakoshi T
J Dermatol Sci; 2023 Oct; 112(1):23-30. PubMed ID: 37661472
[TBL] [Abstract][Full Text] [Related]
33. Expression of laminin-5 gamma 2 chain predicts invasion of extramammary Paget's disease cell.
Tohmatsu Y; Imura J; Sakai T; Takagi K; Minamisaka T; Tanaka S; Noguchi A; Nakajima T; Nagata T; Makino T; Shimizu T; Fujii T
APMIS; 2021 Jan; 129(1):3-8. PubMed ID: 32996218
[TBL] [Abstract][Full Text] [Related]
34. Intratumor dihydropyrimidine dehydrogenase mRNA expression levels are decreased in extramammary Paget's disease.
Nakamura Y; Kajihara I; Yamada-Kanazawa S; Maeda-Otsuka S; Johno T; Aoi J; Igata T; Masuguchi S; Fukushima S; Jinnin M; Ihn H
Drug Discov Ther; 2017 Jul; 11(3):152-155. PubMed ID: 28603180
[TBL] [Abstract][Full Text] [Related]
35. Androgen receptor, androgen-producing enzymes and their transcription factors in extramammary Paget disease.
Azmahani A; Nakamura Y; Ozawa Y; McNamara KM; Fujimura T; Haga T; Hashimoto A; Aiba S; Sasano H
Hum Pathol; 2015 Nov; 46(11):1662-9. PubMed ID: 26359540
[TBL] [Abstract][Full Text] [Related]
36. Clinical and dermoscopic features of extramammary Paget's disease: A retrospective analysis of 49 cases.
Chen L; Yang N; Jiang F; Shao J; Ye Y; Zhu J; Li Z; Liu J
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103105. PubMed ID: 36075520
[TBL] [Abstract][Full Text] [Related]
37. Depigmented genital extramammary Paget's disease: a possible histogenetic link to Toker's clear cells and clear cell papulosis.
Chen YH; Wong TW; Lee JY
J Cutan Pathol; 2001 Feb; 28(2):105-8. PubMed ID: 11168760
[TBL] [Abstract][Full Text] [Related]
38. Detection of
Dong L; Zhu Y; Wu L; Zhang Q; Xu F; Zhang X; Xu X; Tang Y; Ren G; Kang Z; Guan M
J Oncol; 2021; 2021():5514426. PubMed ID: 34759969
[TBL] [Abstract][Full Text] [Related]
39. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease.
Cho Z; Konishi E; Kanemaru M; Isohisa T; Arita T; Kawai M; Tsutsumi M; Mizutani H; Takenaka H; Ozawa T; Tsuruta D; Katoh N; Asai J
J Dermatol Sci; 2017 Jul; 87(1):29-35. PubMed ID: 28381343
[TBL] [Abstract][Full Text] [Related]
40. Extramammary Paget's disease with the appearance of a nodule: a case report.
Wang X; Yang W; Yang J
BMC Cancer; 2010 Aug; 10():405. PubMed ID: 20684770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
